Gary Heller, DO
Dermatology · Pinellas Park, FLNPI 1942255005
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,883 of the $2,711 with a category attached, or 69.4%. 21 manufacturers reported payments, led by GE HealthCare at 27.7% of the total. Reporting peaked in 2021 at $1,576 and has fallen 97.0% since, to $48 in 2025. That places this record below the midpoint for dermatology clinicians in FL, where the typical reported total is $2,563.
Across 103 payments — averaging $26.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GE HealthCare$750
- Paratek Pharmaceuticals, Inc.$550
- AbbVie$270
- Sanofi$197
- Regeneron Healthcare Solutions, Inc.$174
- Pfizer$80
- plus $691 from 15 others
Across 46 payments — averaging $1936.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$75K
- Dermavant Sciences, Inc.$7K
- Perrigo Company PLC$5K
- AbbVie$3K
What the payments were for
- Speaking & faculty fees$75028%
- Food & beverage$1,88369%
- Education$783%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GE HealthCare | 1 | $750 |
| Paratek Pharmaceuticals, Inc. | 38 | $550 |
| AbbVie | 14 | $270 |
| Sanofi | 7 | $197 |
| Regeneron Healthcare Solutions, Inc. | 5 | $174 |
| Pfizer | 5 | $80 |
| UCB, Inc. | 2 | $76 |
| Bristol Myers Squibb | 4 | $72 |
| Sensus Healthcare, Inc. | 1 | $69 |
| LEO Pharma Inc. | 3 | $66 |
| Johnson & Johnson | 4 | $60 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Amgen | 2 | $48 |
| Sun Pharmaceutical Industries Inc. | 3 | $47 |
| Lilly USA, LLC | 2 | $40 |
| Dermavant Sciences, Inc. | 2 | $37 |
| Dermira, Inc. | 2 | $27 |
| Merz North America, Inc. | 1 | $27 |
| Merck | 2 | $23 |
| Novartis | 1 | $23 |
| Organogenesis Inc. | 1 | $16 |
How this compares
$2,711 in reported general payments places this provider in the 50th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 13 | $62,645 |
| Triamcinolone Acetonide | 179 | $1,894 |
| Betamethasone Dipropionate | 46 | $1,816 |
| Clindamycin Phosphate | 51 | $1,340 |
| Cephalexin | 161 | $747 |
| Mupirocin | 92 | $692 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 32 | $681 |
| Hydrocortisone | 128 | $547 |
| Ketoconazole | 28 | $386 |
| ValacyclovirValacyclovir Hcl | 23 | $339 |
| Doxycycline Hyclate | 20 | $252 |
| Hydroxyzine Hcl | 19 | $131 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $81 |
| Prednisone | 23 | $51 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $48 | $62,64513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,147 dermatology providers in Florida.
Other dermatology in Pinellas Park
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.